BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
日曜日, 9 27

HeartSciences Inc

HSCSNASDAQ
Trade with Public
Trade with Public
$4.73
0.102.16%
近くで: Sep 25, 5:00 PM EST
$4.66
-0.07-1.48%
時間外: Sep 25, 5:46 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

HeartSciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for HeartSciences (HSCS).

Price Target Range — 5 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$10Upside to Avg. PT+114.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →
DateFirmAnalystActionRating ChangePrice Target
Mar 24, 2026Ascendiant CapitalLucas WardPT CutBuy$9→$8
Dec 22, 2025Ascendiant CapitalLucas WardPT RaiseBuy$9→$9
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $8

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $9.2 to $8.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on HeartSciences, Raises Price Target to $9.2

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and raises the price target from $9 to $9.2.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $9

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 to $9.
Benzinga Newsdesk

PRO
Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $14

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:HSCS) with a Buy and lowers the price target from $15 to $14.
Benzinga Newsdesk

PRO
Maxim Group Reiterates Buy on HeartSciences, Maintains $12 Price Target

Maxim Group analyst Allen Klee reiterates HeartSciences (NASDAQ:HSCS) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
Ascendiant Capital Reiterates Buy on Heart Test Laboratories, Maintains $15 Price Target

Ascendiant Capital analyst Lucas Ward reiterates Heart Test Laboratories (NASDAQ:HSCS) with a Buy and maintains $15 price target.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved